Why Kolabtree

Getting started is quick and easy. No upfront fees

It’s free to request a service and invite bids from experts

Discuss requirements with the expert in detail before accepting statement of work from Kolabtree

Collaborate with the expert directly to get your work done the right way

Fund project when you hire the expert, but approve the deliverables only once work is done

Contact Jeysen Y.

Contact

Why Kolabtree

Want to hire this expert for a project? Request a quote for free.

Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 250 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Jeysen Y.

Canada

USD 250 /hr

Biotech Clinical Development Executive

Profile Summary

I have 15 years of drug clinical development experience in biotechnology/pharmaceutical organizations of various sizes. My clinical development experience is underpinned by 11 years of medical, surgical and academic experience. My industry exposure, in both rare and non-rare diseases, has enabled me to cultivate a strong and diverse foundation for adult and pediatric drug development following deep involvement in the clinical development of 4 anti-hepatitis B virus (HBV) direct-acting antiviral small molecules, one anti-HBV small interfering ribonucleic acid. (siRNA), one anti-HBV Oligonucleotide Polymer, two immune-based (agonist) anti-HBV small molecule, one anti-HBV therapeutic vaccine, 6 chronic hepatitis C direct-acting antiviral small molecules, one chronic hepatitis C antiviral biologic molecule, one hepatitis Delta (D; rare disease) antiviral small molecule, one hepatitis Delta antiviral biologic molecule, one human immunodeficiency virus (HIV) direct-acting antiviral small molecule, one influenza direct-acting antiviral small molecule, one herpes simplex virus (HSV; shingles) vaccine, one oncology small molecule, one immune-based (antagonist) ultra-rare disease (ROSAH Syndrome) small molecule, one immune-based anti-inflammatory small molecule, one chronic kidney disease small molecule and one cardiac biologic. To date, as a drug developer, I have led led and managed cross functional clinical development teams that are based on-site or remotely at various global locations. I have also led the strategic planning, development and execution of global clinical development plans and clinical trials ranging from First In-Man Phase 1 to Phase 4 single and multi-center studies. I have also been part of diligence teams that led to the in-licensing of molecules for further development in clinical trials. From these multiple clinical trials, I have demonstrated a capacity to successfully manage and lead cross-functional global teams, both virtually and in-person. Having held local, regional and global positions in the UK, Europe and the USA, respectively, I have excellent cross-cultural organizational working experience. I am recognized as an emotionally intelligent leader of people who is adaptable, dynamic, analytic and creative

Subject Matter Expertise

Services

Writing
Research
Consulting
Product Development

Writing Clinical Trial Documentation, Medical Writing

Research Scientific and Technical Research

Consulting Scientific and Technical Consulting

Product Development Concept Development

Work Experience

Chief Medical Officer

Drug Farm

May 2021 - Present

Education

MBA

Massachusetts Institute of Technology

September 2013 - May 2015

PhD

University of Hull, UK

April 2004 - April 2011

MRCSEd

Royal College of Surgeons of Edinburgh

August 1999 - September 2002

MB.BCh, BAO

Royal College of Surgeons - Ireland

October 1993 - May 1999

Certifications

Certification details not provided.